Last reviewed · How we verify

NCT07026188

Ultrasound Combined With SMI Imaging on Children With Limb Lengthening

Completed Last updated 18 June 2025
What this trial tests

trial testing Ultrasound with SMI in Bone Anomalies in 63 participants. Completed in 31 January 2025.

Timeline
25 December 2021
Primary endpoint
1 June 2024
31 January 2025

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment63
Start date25 December 2021
Primary completion1 June 2024
Estimated completion31 January 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Under 18, any sex, with Bone Anomalies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the present study, The use of ultrasound allows observation of new bone formation in the distraction gap, also visualize the formation of blood vessels in the distraction gap, including the velocity and resistance of blood vessels, and can also indicate the environment of new bone formation. It's considered that ultrasound detection of new bone and angiogenesis in the process of bone lengthening in children could be a good supplement to X-ray evaluation, and even partially replace the former, reducing the radiation burden of pediatric patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07026188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing